BDRX (Biodexa Pharmaceuticals Plc) Stock Market Reviews

crown

Read and share opinions on BDRX (Biodexa Pharmaceuticals Plc) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

BDRX

Biodexa Pharmaceuticals Plc

clarify Biotechnology

bookmark Healthcare

public United Kingdom

Sell Neutral Buy

Latest News

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion
Nov 3, 2025
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
Oct 6, 2025

Sign In

Stock Market Reviews

BDRX

Biodexa Pharmaceuticals Plc

Latest News

Reviews

Our use of cookies